Juan M. Pericas-rekin lankidetzan egindako argitalpenak (3)

2024

  1. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal

2023

  1. Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

    Contemporary Clinical Trials, Vol. 134

2022

  1. Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

    Liver International, Vol. 42, Núm. 8, pp. 1783-1792